Estrogen and progestogen therapy in advanced ovarian cancer: Preliminary report
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 16 (3) , 352-359
- https://doi.org/10.1016/0090-8258(83)90162-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Ovarian carcinoma: Histologic and clinical correlation of cytoplasmic estrogen and progesterone bindingGynecologic Oncology, 1981
- High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapyGynecologic Oncology, 1981
- The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovaryCancer, 1981
- A Study of Estrogen and Progesterone Cytosol Receptor Concentration in Benign and Malignant Ovarian Tumors and A Review of Malignant Ovarian Tumors Treated with Medroxy‐Progesterone AcetateActa Obstetricia et Gynecologica Scandinavica, 1981
- Progesterone receptors: Saturation analysis by a solid phase hydroxylapatite adsorption techniqueCancer, 1980
- Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovaryInternational Journal of Cancer, 1980
- Do Estrogen and Progesterone Receptors (E2R and PR) in Metastasizing Endometrial Cancers Predict the Response to Gestagen Therapy?Acta Obstetricia et Gynecologica Scandinavica, 1980
- Treatment of epithelial carcinoma of the ovary: Operation, irradiation, and chemotherapyAmerican Journal of Obstetrics and Gynecology, 1977
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949